Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-001 in Severe Heart Failure Secondary to Ischemic Heart Disease
NCT04945018Phase 2Completed
- Sponsor
- Heartseed Inc.
- Start
- Apr 2022
- Primary completion
- Jul 2025
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of HS-001 in heart failure (HF), ischemic heart disease (IHD), sponsored by Heartseed Inc.. Started Apr 2022; status: completed.
02
Drugs
HS-001
03
Conditions
heart failure (HF)ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT04945018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04945018.